BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17179913)

  • 1. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
    Shin V; Bhargava P; Brown J; Ames ED; Kang P
    Med Sci Monit; 2007 Jan; 13(1):CS4-8. PubMed ID: 17179913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
    Saadé-Yordán C; McBurney-Henriquez E; González-Santoni R; Gurrea-Rosas C; Montalvo-Fitzpatrick J; Maldonado-Vargas JA
    Am J Case Rep; 2017 Dec; 18():1390-1395. PubMed ID: 29282351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary carcinoid tumors].
    Prosch H
    Radiologe; 2017 May; 57(5):397-406. PubMed ID: 28405692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
    Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
    Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
    Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
    J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
    Gasparri R; Rezende GC; Fazio N; Maisonneuve P; Brambilla D; Travaini LL; Paganelli G; Petrella F; Galetta D; Spaggiari L
    Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):446-54. PubMed ID: 26416036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
    Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
    AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT).
    Tanabe Y; Sugawara Y; Nishimura R; Hosokawa K; Kajihara M; Shimizu T; Takahashi T; Sakai S; Sawada S; Yamashita M; Ohtani H
    Ann Nucl Med; 2013 Oct; 27(8):781-5. PubMed ID: 23757317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?
    Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I
    Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
    Himpe U; Deroose CM; Leyn PD; Verbeken E; Vansteenkiste J
    J Thorac Oncol; 2009 Jan; 4(1):107-8. PubMed ID: 19096317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic imaging of typical lung carcinoids: relationship between MDCT,
    Danti G; Berti V; Abenavoli E; Briganti V; Linguanti F; Mungai F; Pradella S; Miele V
    Radiol Med; 2020 Aug; 125(8):715-729. PubMed ID: 32189174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typical and atypical bronchopulmonary carcinoid tumors on FDG PET/CT imaging.
    Wartski M; Alberini JL; Leroy-Ladurie F; De Montpreville V; Nguyen C; Corone C; Dartevelle P; Pecking AP
    Clin Nucl Med; 2004 Nov; 29(11):752-3. PubMed ID: 15483502
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
    Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of pulmonary typical carcinoid with an extensive oncocytic component showing intense uptake of FDG.
    Kadowaki T; Yano S; Araki K; Tokushima T; Morioka N
    Thorax; 2011 Apr; 66(4):361-2. PubMed ID: 21075777
    [No Abstract]   [Full Text] [Related]  

  • 16. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours?
    Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
    Eur J Cardiothorac Surg; 2017 May; 51(5):874-879. PubMed ID: 28204100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of (18)-FDG and (68)Ga-DOTATOC PET-CT to differentiate endobronchial carcinoids and inflammatory myofibroblastic tumors.
    Jindal T; Kumar A; Dutta R; Kumar R
    J Postgrad Med; 2009; 55(4):272-4. PubMed ID: 20083875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solitary choroidal metastasis from atypical carcinoid of the lung detected by (68)Ga DOTATATE PET/CT.
    Rapicetta C; Falco F; Roncali M; Treglia G; Carbonelli C; Paci M; Marchi S; Lococo F
    Clin Nucl Med; 2015 Jun; 40(6):e319-20. PubMed ID: 25546202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous occurrence of typical carcinoid and non-small-cell lung cancer in the same lung lobe: value of nuclear medicine.
    Khreish F; Hellwig D; Mathews J; Bücker A; Kirsch CM; Grgic A
    Clin Nucl Med; 2011 Jun; 36(6):481-3. PubMed ID: 21552033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.